PUBLIC CONTRACT · 2022
4180378/2022 - Aq. Central P1330 - Pembrolizumab 100 mg (25 mg/ml frs 4 ml) sol inj
- Contract value
- €33,000.00
- Signed on
- 15 November 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9859826PUBLISHED SUBJECT
4180378/2022 - AQ. CENTRAL P1330 - PEMBROLIZUMAB 100 MG (25 MG/ML FRS 4 ML) SOL INJ
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- MERCK SHARP DOHME · Tax ID 500191360
Values and timeline
- Contract price
- €33,000.00
- Procedure base price
- €33,000.00
- Total effective price
- €33,000.00
- Publication date
- 13 March 2023
- Award date
- 15 November 2022
- Signing date
- 15 November 2022
- Performance period
- 21 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6393830
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.